Clinical Trial Update: GLS-1200 Topical Nasal Spray to Prevent Sinusitis After Endoscopic Sinus Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial update for GLS-1200 topical nasal spray aimed at preventing sinusitis after endoscopic sinus surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sinusitis

Drugs mentioned

• GLS-1200

Snippet

Sponsor: GeneOne Life Science, Inc. | Conditions: Sinusitis Chronic | Phase 2 | Status: UNKNOWN